Skip to content

Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population

Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05365399
Enrollment
180
Registered
2022-05-09
Start date
2022-05-03
Completion date
2022-08-15
Last updated
2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Jaundice

Brief summary

The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara.

Detailed description

The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara. The specific objectives for this study are: To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin measurements in serum in newborns with varying degree of jaundice To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin estimates from a standard transcutaneous device in newborns with varying degree of jaundice To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin estimates from visual inspection in newborns with varying degree of jaundice

Interventions

DEVICEsmartphone-based screening tool for neonatal jaundice

In this study we aim to collect data of newborns with wider range of bilirubin levels and high melanin content, and additionally measurements of skin color reflectance with a spectrophotometer, to adjust the Picterus JP algorithm and optimize the app performance. This will enable a high qualitative estimation of bilirubin levels in the blood of new-borns for all skin colors. .

Sponsors

Norwegian University of Science and Technology
CollaboratorOTHER
Picterus AS
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
24 Hours to 14 Days
Healthy volunteers
Yes

Inclusion criteria

* Infants born with gestational age ≥37 weeks * Birth weight ≥2000g and ≤4500g * Age 1 - 14 days * Infants requiring a blood sample (newborn screening / clinically suspected jaundice)

Exclusion criteria

* Infants transferred to the paediatric ward for advanced treatment. * Infants with a skin rash or other disease that affects the skin where measurements are performed. * Infants that receive or have received phototherapy in the last 24 hours. * Infants with an inborn disease

Design outcomes

Primary

MeasureTime frameDescription
Smartphone application sensitivity (bilirubin levels on newborns)5 minutesEnable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Secondary

MeasureTime frameDescription
Smartphone application sensitivity (bilirubin levels on newborns with high melanin content) in the skin.5 minutesEnable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP. Adapt the current algorithm of Picterus JP to newborns with high melanin content in the skin

Countries

Uganda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026